Direct costs of acute day hospital care: Results from a randomized controlled trial;Direkte kosten akutpsychiatrischer tagesklinischer behandlung: Ergebnisse aus einer randomisierten kontrollierten studie

Psychiatrische Praxis

Volumn 32, Issue 3, 2005, Pages 132-141

  Kallert, Thomas W ^a   Schönherr, Ralf ^b   Schnippa, Susann ^b   Matthes, Christiane ^a   Glöckner, Matthias ^a   Schützwohl, Matthias ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAY CARE; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADJUSTMENT DISORDERS; ADULT; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; DAY CARE; FEMALE; FOLLOW-UP STUDIES; FORMALDEHYDE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MOOD DISORDERS; NATIONAL HEALTH PROGRAMS; PATIENT ADMISSION; PSYCHIATRIC DEPARTMENT, HOSPITAL; QUATERNARY AMMONIUM COMPOUNDS; SCHIZOPHRENIA; UTILIZATION REVIEW;

EID: 17444404164     PISSN: 03034259     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-834712     Document Type: Article

References (44)

1. Melchinger H, Machleidt W, Rössler W. Psychiatrische Versorgung: Ausgaben auf dem Prüfstand. Dtsch Ärztebl 2003; 100: A 2850-2852
2. Brenner HD, Junghan U, Pfammater M. Gemeindeintegrierte Akutversorgung. Grenzen und Möglichkeiten. Nervenarzt 2000; 71: 691-699
3. Arbeitsgruppe Psychiatrie der obersten Landesgesundheitsbehörden. Bestandsaufnahme zu den Entwicklungen der Psychiatrie in den letzten 25 Jahren. 2003
4. Kallert TW, Schützwohl M, Glöckner M, Priebe S, Briscoe J, Rymaszewska J, Adamowski T, Nawka T, Reguliova T, Raboch J, Howardova A. A comparison of psychiatric day hospitals in five European countries: implications of their diversity for day hospital research. Soc Psychiatry Psychiat Epidemiol 2004; 39: 777-788
5. Kallert TW, Matthes C, Glöckner M, Eichler T, Koch R, Schützwohl M. Akutpsychiatrische tagesklinische Behandlung: ein effektivitätsgesichertes Versorgungsangebot? Psychiat Prax 2004; 31: 409-419
6. Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D. Day hospital versus admission for acute psychiatric disorders (Cochrane Review). Oxford: The Cochrane Library, Update Software, 2003; (3)
7. Creed F, Black D, Anthony P, Osborn M, Thomas P, Tomenson B. Randomised controlled trial of day patient versus inpatient psychiatric treatment. BMJ 1990; 300: 1033-1037
8. Creed F, Mbaya P, Lancashire S, Tomenson B, Williams B, Holme S. Cost effectiveness of day and inpatient psychiatric treatment. BMJ 1997; 314: 1381-1385
9. Dick P, Cameron L, Cohen D, Barlow M, Ince A. Day and full time psychiatric treatment: a controlled comparison. Brit J Psychiatry 1985; 147: 246-249
10. Wiersma D, Kluiter F, Nienhuis F, Ruphan M, Giel R. Costs and benefits of day treatment with community care of affective and schizophrenic disorders. Brit J Psychiatry 1995; 166: 52-59
11. Sledge WH, Tebes J, Wolff N, Helminiak TW. Day hospital/crisis respite versus inpatient care, part II: service utilization and costs. Am J Psychiatry 1996; 153: 1074-1083
12. Endicott J, Herz J, Gibbon M. Brief vs. standard hospitalization: The differential costs. Am J Psychiatry 1978; 135: 707-712
13. Newton PA. An evaluation of the cost effectiveness of day hospitalization for black male schizophrenics. J Natl Med Assoc 1983; 75: 273-285
14. Washburn S, Vannicelli M, Longabaugh R, Scheff B-J. A controlled comparison of psychiatric day treatment and inpatient hospitalization. J Consult Clin Psychol 1976; 44: 665-675
15. Horvitz-Lennon M, Normand SLT, Gaccione P, Frank RG. Partial versus full hospitalization for adults in psychiatric distress: A systematic review of the published literature (1957-1997). Am J Psychiatry 2001; 158: 676-685
16. Kallert TW, Schützwohl M. Randomisierte kontrollierte Studien in der psychiatrischen Versorgungsforschung: Probleme der Durchführungspraxis. Fortschr Neurol Psychiat 2002; 70: 647-656
17. Kallert TW, Schützwohl M, Matthes C, EDEN-study group. The Client Socio-Demographic and Clinical History Inventory. Dresden: University of Technology, Faculty of Medicine, Dresden, 2000
18. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes, second edition. Oxford: Medical Publications, Oxford, 1997
19. Knapp M, Beecham J. Health economics and psychiatry: the pursuit of efficiency. In: Bhugra D, Leff J: Principles of Social Psychiatry. Oxford: Blackwell Scientific Publications, 1993: 549-561
20. Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, Wijngaarden B van and the EPSILON study group. Client Socio-Demographic and Service Receipt Inventory - European Version: development of an instrument for international research. Brit J Psychiatry 2000; 177, suppl 39: s28-s33
21. Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC. Die deutsche Version des Client Sociodemographic and Service Receipt Inventory. Ein Instrument zur Erfassung psychiatrischer Versorgungskosten. Psychiat Prax 2001; 28, Sonderheft 2: S84-S90
22. Netten A, Beecham J (eds). Costing community care: theory and practice. Personal Social Services Research Unit (PSSRU), University of Kent at Canterbury. Cambridge: University Press, 2003
23. Schönherr R, Günther T. European Day hospital Evaluation (EDEN). Teilprojekt KOKA - Kostenkalkulation von Versorgungsleistungen in Deutschland. (Unveröffentlichter Projektbericht). TU Dresden: Fakultät Wirtschaftswissenschaften, Dresden, 2003
24. Salize HJ, Stamm K, Schubert M, Bergmann F, Härter M, Berger M, Gaebel W, Schneider F. Behandlungskosten von Patienten mit Depressionsdiagnose in haus- und fachärztlicher Versorgung in Deutschland. Psychiat Prax 2004; 31: 147-156
25. KBV (Hrsg). Einheitlicher Bewertungsmaßstab (EBM) mit den Vertragsgebührenordnungen, Bewertungsmaßstab für ärztliche Leistungen (BMA) und der Ersatzkassen-Gebührenordnung (E-GO). Köln: Deutscher Ärzteverlag, 2001
26. Knappe E, Neubauer G, Seeger T, Sullivan K. Die Bedeutung von Medizinprodukten im deutschen Gesundheitswesen, Studie im Auftrag von HIMA (Washington, USA), EU-COMED/EDMA (Brüssel) und BVMed (Wiesbaden). Mai 2000 http://www.bvmed.de Abruf am 2003-10-24
27. Salize HJ, Rössler W. Kosten und Kostenwirksamkeit der gemeindepsychiatrischen Versorgung von Patienten mit Schizophrenie. Berlin: Springer, 1998
28. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ 1998; 317: 1195-1200
29. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320: 1197-1200
30. Rote Liste Service GmbH (Hrsg). Rote Liste 2002. Aulendorf: Editio Cantor, 2002
31. Knapp M, Beecham J. Costing mental health services. Psychol Med 1990; 20: 893-908
32. Hu TW, Hargreaves WA, Shumway M. Estimating costs of schizophrenia and its treatment. In: Moscarelli M, Rupp A, Sartorius N (eds): Handbook of Mental Health Economics and Health Policy, Volume I, Schizophrenia. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley & Sons, 1996: 359-371
33. Hollis S, Campbell F. What is meant by intention to treat analysis. Survey of published randomized trials. BMJ 1999; 319: 670-674
34. Briggs A, Wonderling D, Mooney C. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Economics 1997; 6: 327-340
35. Rutten-van Mölken M, Coorslaer E van, Vliet R van. Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Economics 1994;3:333-345
36. Briggs A. Handling uncertainty in economic evaluation. BMJ 1999; 319: 120
37. Briggs A. Handling uncertainty in economic evaluation of healthcare interventions. BMJ 1999; 319: 635-638
38. Schulenberg JM Graf von der, Greiner W. Gesundheitsökonomik. Tübingen: Mohr Siebeck, 2000
39. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourna D, Gøtzsche PC, Lang T. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134: 663-694
40. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355: 1064-1069
41. Kissling W, Hoffler J, Seemann U, Müller P, Rüther E, Trenckmann U, Uber A, Schulenberg JM Graf von der, Glaser P, Glaser T, Mast O, Schmidt D. Die direkten und indirekten Kosten der Schizophrenie. Fortschr Neurol Psychiatr 1999; 67: 29-36
42. Gray AM, Marshall M, Lockwood A, Morris J. Problems in conducting economic evaluations alongside clinical trials. Lessons from a study of case management for people with mental disorders. Brit J Psychiatry 1997; 170: 47-52
43. Al MJ, Hout BA van, Michel BC, Rutten FFH. Sample size calculation in economic evaluations. Health Econ 1998; 7: 327-335
44. Roick C, Angermeyer MC. Ökonomie und Praxis. Psychiat Prax 2004; 31: 115-117